Anaplastic Lymphoma Kinase Positive Aggressive Adult Lung Primary Inflammatory Myofibroblastoma Tumor: A Case and Literature Review
Pharmacogenomics and Personalized Medicine · 2026-07 · Volume 19 · 1-7
DOI: 10.2147/pgpm.s591506 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pharmacogenomics and Personalized Medicine, 2026-07. Verfasst von Panfeng Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, Pe…. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China.
Zitieren
APA
Xu, P., & Lu, S. (2026). Anaplastic Lymphoma Kinase Positive Aggressive Adult Lung Primary Inflammatory Myofibroblastoma Tumor: A Case and Literature Review. Pharmacogenomics and Personalized Medicine, Volume 19, 1-7. https://doi.org/10.2147/pgpm.s591506
Vancouver
Xu P, Lu S. Anaplastic Lymphoma Kinase Positive Aggressive Adult Lung Primary Inflammatory Myofibroblastoma Tumor: A Case and Literature Review. Pharmacogenomics and Personalized Medicine. 2026;Volume 19:1-7. doi:10.2147/pgpm.s591506
BibTeX
@article{Xu2026,
author = {Xu, Panfeng and Lu, Shan},
title = {Anaplastic Lymphoma Kinase Positive Aggressive Adult Lung Primary Inflammatory Myofibroblastoma Tumor: A Case and Literature Review},
journal = {Pharmacogenomics and Personalized Medicine},
year = {2026},
volume = {Volume 19},
pages = {1--7},
doi = {10.2147/pgpm.s591506}
}
EUVIMED